We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Syp3.0
Soy Peptides Research
Mostly mechanism / observational
16 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Soy Peptides studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 2007–2026 with a typical study size of 31 participants.
Based on 16 studies · 3 RCTs · 31 total participants
Confidence
Moderate confidence
By outcome
Heart & blood pressurePlausible LDL-cholesterol and blood-pressure benefit via LDL-receptor up-regulation and ACE inhibition — but demonstrated mostly in vitro/in animals; the one human lunasin RCT was null · Weeks (uncertain — not established in humans)
Mostly mechanism / observational6 studies
Antioxidant & oxidative stress
Mostly mechanism / observational6 studies
Cholesterol & lipidsPlausible LDL-cholesterol and blood-pressure benefit via LDL-receptor up-regulation and ACE inhibition — but demonstrated mostly in vitro/in animals; the one human lunasin RCT was null · Weeks (uncertain — not established in humans)
Mostly mechanism / observational5 studies
Glucose & metabolicSoy peptides are studied for metabolic/insulin-resistance endpoints, but human glucose data are essentially absent (the lunasin RCT found no glucose change) · Unknown
Too few graded studies1 study
Safety profile
Too few graded studies1 study
Active research area
6 studies in the last 5 years
200720162026
1RCT2019
Imaoka M, Nakao H, Nakamura M, Tazaki F, Maebuchi M, Ibuki M · Clin Interv Aging (2019)
In plain English: In conclusion, lunasin is a promising multifunctional bioactive peptide, yet further research is required to optimize and expedite its application in the food industry.
Fan X, Zhang Z, Hu Y, Richel A, Wang F, Zhang L, Ren G, Zou L. · Food chemistry (2025)
This review summarizes the content of lunasin in soybeans, soy derived foods, and other crops, as well as its structural characteristics and bioavailability.
Moreover, we focused on the relationship between the physicochemical characteristics and structural composition of lunasin, and its significance for the bioactivities of lunasin.
Ultimately, the therapeutic effects of lunasin on cancer, oxidative stress, inflammation, immune response, and hyperlipidemia were described, as well as the molecular mechanisms involved in these impacts.
In plain English: This document aims to compile the advances in the research on lunasin-like peptides and their bioactivities to have a better understanding of the current advances related to these peptides.
Gutiérrez-López JO, Castañeda-Reyes ED, Dávila-Ortiz G. · International journal of environmental research and public health (2025)
It is worth mentioning that the in silico analyses of proteins in which the lunasin-like peptide is located have been developed in some of these seeds; however, more studies are needed in order to confirm sequence similarity to that of the lunasin peptide.
This document aims to compile the advances in the research on lunasin-like peptides and their bioactivities to have a better understanding of the current advances related to these peptides.
In plain English: This combination-oriented paradigm may represent a shift in lunasin research and offer a novel direction for the use of bioactive peptides in precision oncology; however, further studies exploring this possibility, including human clinical trials, are needed to elucidate lunasin's role in nutraceutical-assisted cancer therapy.
Janiak A, Kaufman-Szymczyk A, Lubecka-Gajewska K. · International journal of molecular sciences (2026)
In combination with those drugs, lunasin exerts significant anticancer effects at concentrations substantially lower than those proven as effective in monotherapy, suggesting a potential role in dose reduction in conventional agents and, subsequently, mitigation of their adverse effects.
Although the enhanced effect of those combinations has been shown in preclinical models, there is a distinct lack of human clinical trials in this matter.
Available evidence supports a promising concept of lunasin as a molecular "priming" agent that might complement cytotoxic therapies rather than replace them.
In plain English: Supplementation with lunasin-enriched soy extract for 8 weeks did not result in significant changes in serum lipids, glucose, insulin resistance, blood pressure, BMI, or waist circumference.
Haddad Tabrizi S, Haddad E, Rajaram S, Oda K, et al. · J Diet Suppl (2020)
Triple-blind, placebo-controlled crossover RCT in 31 adults (mean age 61), 8-week lunasin-enriched soy extract 335 mg/day with a 3-week washout
Nonsignificant reductions across total cholesterol, LDL, triglycerides, fasting glucose, BMI and waist circumference — none reached significance
Authors concluded a higher dose, larger sample, and/or longer treatment are needed to determine any independent lunasin effect
In plain English: Many soy bioactive peptides... have a variety of physiological functions such as hypolipidemic, anti-hypertensive, and anti-cancer properties... However, more studies are required to further identify their target organs, and elucidate their biological mechanisms of action.
In plain English: Soy bioactive compounds may mitigate chronic inflammation. However, more human intervention studies are needed to assess their efficacy.
Kusumah J, Gonzalez de Mejia E. · Food Res Int (2022)
Systematic review of soybean bioactive compounds (including peptides) and diet-induced chronic inflammation, 2012-2022
Mechanism centers on inhibition of the NF-κB pathway and reduced inflammatory markers
Explicitly concludes that human intervention studies are lacking and needed
In plain English: Among these compounds, the peptide lunasin is considered as one of the most promising... against chronic diseases such as cancer, cardiovascular and immunological disorders.
Hsieh CC, Martínez-Villaluenga C, de Lumen BO, Hernández-Ledesma B. · J Sci Food Agric (2018)
Review of lunasin: presence in soybean/derived foods, oral bioavailability, and protective effects
Covers protective/therapeutic effects against cancer, oxidative stress, inflammation, and high cholesterol
Emphasizes mechanisms remain largely preclinical (cell and animal models)
In plain English: Lunasin possesses inherent antioxidative, anti-inflammatory, anticancerous properties and could also play a vital role in regulating of cholesterol biosynthesis in the body.
In plain English: The bioactivity is due to soybean peptides because the ethanol extract of soybean protein which contains isoflavones does not stimulate LDL-R transcription.
Cho SJ, Juillerat MA, Lee CH. · J Agric Food Chem (2007)
Cell-based study: soybean protein hydrolysate (SPH) peptides stimulated LDL-receptor transcription in Hep T9A4 hepatocytes
Effect tracked the peptides (fractions ~200 and 3000 Da), NOT the isoflavone-containing ethanol extract — key distinction from soy isoflavones
Mechanism is up-regulation of LDL-R, not blockage of bile-acid/cholesterol absorption or inhibition of cholesterol synthesis
In plain English: Peptides corresponding to the N-terminal and central regions of lunasin were demonstrated to inhibit angiotensin converting enzyme and to scavenge peroxyl and ABTS radicals.
Indiano-Romacho P, Fernández-Tomé S, Amigo L, Hernández-Ledesma B. · Food Res Int (2019)
Lunasin and its digestion-derived fragments inhibited ACE and scavenged peroxyl/ABTS radicals in vitro
Suggests bioactivity survives (in fragment form) gastrointestinal proteolysis — partially addressing the bioavailability concern
Links the antioxidant and blood-pressure mechanisms to the same peptide family
In plain English: This peptide... demonstrated to be a potent scavenger of peroxyl and superoxide radicals... preventing of the oxidative damage induced by both chemical agents.
García-Nebot MJ, Recio I, Hernández-Ledesma B. · Food Chem Toxicol (2014)
Lunasin was a potent scavenger of peroxyl and superoxide radicals in vitro
Protected human Caco-2 intestinal cells against H2O2- and tert-butylhydroperoxide-induced oxidative damage
Remained partially intact during cell incubation, supporting intestinal-level activity